🇺🇸 FDA
Patent

US 6214571

Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cells

expired A61KA61K31/198

Quick answer

US patent 6214571 (Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cells) held by The Regents of the University of California expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/198